Nanoparticulate fingolimod delivery system based on biodegradable poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV): design, optimization, characterization and in-vitro evaluation

References

• Kluepfel D, Bagli J, Baker H, et al. Myriocin, a new antifungal antibiotic from Myriococcum albomyces. J Antibiot 1972; 25: 109–115
   Google Scholar
• Strader CR, Pearce CJ, Oberlies NH. Fingolimod (FTY720): a recently approved multiple sclerosis drug based on a fungal secondary metabolite. J Nat Prod 2011;74:900–907
   PubMed Web of Science ®Google Scholar
• Albert R, Hinterding K, Brinkmann V, et al. Novel immunomodulator FTY720 is phosphorylated in rats and humans to form a single stereoisomer. Identification, chemical Proof, and biological characterization of the biologically active species and its enantiomer. J Med Chem 2005;48:5373–5377
   PubMed Web of Science ®Google Scholar
• Billich A, Bornancin F, Dévay P, Mechtcheriakova DP, et al. Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases. J Biol Chem 2003;278:47408–47415
   PubMed Web of Science ®Google Scholar
• Brinkmann V, Davis MD, Heise CE, et al. the immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem 2002;277:21453–21457
   PubMed Web of Science ®Google Scholar
• Chiba K. FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors. Pharmacol Ther 2005;108:308–319
   PubMed Web of Science ®Google Scholar
• Brinkmann V. FTY720: mechanism of action and potential benefit in organ transplantation. Yonsei Med J 2004;45:991–997
   PubMed Web of Science ®Google Scholar
• Kang SI, Na K, Bae YH. Physicochemical characteristics and doxorubicin release behaviors of pH/temperature-sensitive polymeric nanoparticles. Colloids Surf. A 2003;231:103–112
   Web of Science ®Google Scholar
• Poletto FS, Ager EJ, ruz L, et al. The effect of polymeric wall on the permeability of drug-loaded nanocapsuls. Mater Sci Eng C 2007;28: 472–478
   Web of Science ®Google Scholar
• Chiellini EE, Chiellini F, Solaro R. Bioerodible polymeric nanoparticles for targeted delivery of proteic drugs. J Nanosci Nanotechnol. 2006;6:3040–3047
   PubMed Web of Science ®Google Scholar
• Reddy ST, Rehor A, Schmoekel HG, et al. In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles. J Control Release 2006;12:26–34
   Web of Science ®Google Scholar
• Huang YY, Chung TW. Microencapsulation of gentamicin in biodegradable PLA and/or PLA/PEG copolymer. J Microencapsul 2001;18:457–465
   PubMed Web of Science ®Google Scholar
• Merisko-Liversidge EM, Liversidge GG. Drug nanoparticles: formulating poorly water-soluble compounds. Toxicologic Pathol 2008;36:43–48
   PubMed Web of Science ®Google Scholar
• Hu J, Johnston KP, Williams RO 3rd, et al. Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs. Drug Dev Ind Pharm 2004;30:233–245
   PubMed Web of Science ®Google Scholar
• Tancourt T, Brown B, Brannon-Peppas L. Doxorubicin-loaded PLGA nanoparticles by nanoprecipitation: preparation, characterization and in vitro evaluation. Nanomedicine (Lond) 2007;2:219–232
   PubMed Web of Science ®Google Scholar
• Reddy LH, Murthy R. Pharmacokinetics and biodistribution studies of doxorubicin loaded poly (butyl cyanoacrylate) nanoparticles synthesized by two different techniques. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2004;148:161–166
   PubMedGoogle Scholar
• Gabizon A, Tzemach D, Mak L, et al. Dose dependency of pharmacokinetics and therapeutic efficacy of pegylated liposomal doxorubicin (DOXIL) in murine models. J Drug Target 2002;10:539–548
   PubMed Web of Science ®Google Scholar
• Panagi Z, Beletsi A, Evangelatos G, et al. Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles. Int J Pharm 2001;221:143–152
   PubMed Web of Science ®Google Scholar
• Chu KS, Hasan W, Rawal S, et al. Plasma, tumor and tissue pharmacokinetics of Docetaxel delivered via nanoparticles of different sizes and shapes in mice bearing SKOV-3 human ovarian carcinoma xenograft. Nanomedicine 2013;9:686–693
   PubMed Web of Science ®Google Scholar
• Li SD, Huang L. Pharmacokinetics and biodistribution of nanoparticles. Molecular Pharmaceutics 2008;5:496–504
   PubMed Web of Science ®Google Scholar
• Averineni RK, Shavi GV, Gurram AK, et al. PLGA 50:50 nanoparticles of paclitaxel: development, in vitro anti-tumor activity in BT-549 cells and in vivo evaluation. Bull Materials Sci 2012;35:319–326
   Web of Science ®Google Scholar
• Noyes AA, Whitney WR. The rate of solution of solid substances in their own solutions. J Am Chem Soc 1897;19:930–934
   Google Scholar
• Rogers TL, Johnston KP, Williams RO III. Solution-based particle formation of pharmaceutical powders by supercritical or compressed fluid CO2 and cryogenic spray-freezing technologies. Drug Dev Ind Pharm. 2001;27:1003–1015
   PubMed Web of Science ®Google Scholar
• Pace SN, Pace GW, Parikh I, Mishra AK. Novel injectable formulations of insoluble drugs. Pharm Technol 1999;3:116–134
   Google Scholar
• Dressman JB, Reppas C. In vitro-in vivo correlation for lipophilic, poorly water-soluble drugs. Eur J Pharm Sci 2000;11:S73–S80
   PubMed Web of Science ®Google Scholar
• Serajuddin ATM. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J Pharm Sci 1999;88:1058–1066
   PubMed Web of Science ®Google Scholar
• Merisko-Liversidge E, Liversidge GG, Cooper ER. Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur J Pharm Sci 2003;18:113–120
   PubMed Web of Science ®Google Scholar
• Santhi K, Dhanaraj SA, Rajendran SD, et al. Nonliposomal approach-a study of preparation of egg albumin nanospheres containing amphotericin-B. Drug Dev Ind Pharm 1999;25:547–551
   PubMed Web of Science ®Google Scholar
• Cherian AK, Rana AC, Jain SK. Self-assembled carbohydrate-stabilized ceramic nanoparticles for the parenteral delivery of insulin. Drug Dev Ind Pharm 2000;26:459–463
   PubMed Web of Science ®Google Scholar
• Muller RH, Peters K. Nanosuspensions for the formulation of poorly soluble drugs I. Preparation by a size-reduction technique. Int J Pharm 1998;160:229–237
   Web of Science ®Google Scholar
• Hazer B. Amphiphilic poly (3-hydroxy alkanoate): potential candidates for medical applications. Int J Polym Sci 2010; 18
   Google Scholar
• Witt U, Eining T, Yamamoto M, et al. Biodegradation of aliphatic-aromatic copolyesters: evaluation of the final biodegradability and ecotoxicological impact of degradation intermediates. Chemosphere 2001;44:289–299
   PubMed Web of Science ®Google Scholar
• Sheu DS, Chen WM, Yang JY, Chang RC. Thermophilic bacterium caldimonas taiwanensis produces poly(3-hydroxybutyrate-co-3-hydroxyvalerate) from starch and valerate as carbon sources. Enz Microbial Technol 2009;44:289–294
   Web of Science ®Google Scholar
• Verlinden RAJ, Hill DJ, Kenward MA, et al. Bacterial synthesis of biodegradable polyhydroxyalkanoates. J Appl Microbiol 2007;102:1437–1449
   PubMed Web of Science ®Google Scholar
• Chen J, Davis S. The release of diazepam from poly(hydroxybutyrate-hydroxyvalerate) microspheres. J Microencapsulation 2002;19:191–201
   PubMed Web of Science ®Google Scholar
• Pacheco DP, Amaral MH, Reis RL, et al. Development of an injectable PHBV microparticles-GG hydrogel hybrid system for regenerative medicine. Int J Pharma 2015;478:398–408
   PubMed Web of Science ®Google Scholar
• Masood F, Chen P, Yasin T, et al. Encapsulation of Ellipticine in poly-(3-hydroxybutyrate-co-3-hydroxyvalerate) based nanoparticles and its in vitro application. Mater Sci Eng C Mater Biol Appl 2013;33:1054–1060
   PubMed Web of Science ®Google Scholar
• Stanwick JC, Baumann MD, Shoichet MS, et al. Enhanced neurotrophin-3 bioactivity and release from a nanoparticle-loaded composite hydrogel. J Control Release 2012;160:666–675
   PubMed Web of Science ®Google Scholar
• Duan B, Wang M. Encapsulation and release of biomolecules from Ca–P/PHBV nanocomposite microspheres and three-dimensional scaffolds fabricated by selective laser sintering. Polym Degrad Stabil 2010;95:1655–1664
   Web of Science ®Google Scholar
• Chandasana H, Prasad YD, Chhonker Y, et al. Corneal targeted nanoparticles for sustained natamycin delivery and their PK/PD indices: an approach to reduce dose and dosing frequency. Int J Pharma 2014;477:317–325
   PubMed Web of Science ®Google Scholar
• Pandey R, Khuller G. Subcutaneous nanoparticle-based antitubercular chemotherapy in an experimental model. J Antimicrob Chemother 2004;54:266–268
   PubMed Web of Science ®Google Scholar
• Reis CP, Neufeld RJ, Ribeiro AJ, Veiga F. Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. Nanomedicine 2006;2:8–21
   PubMed Web of Science ®Google Scholar
• Motwani SK, Chopra S, Talegaonkar S, et al. Chitosan–sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in-vitro characterisation. Europ J Pharm Biopharm 2008;68:513–525
   PubMed Web of Science ®Google Scholar
• Harrington E. The desirability function. Indust Quality Control 1965;21:494–498
   Google Scholar
• Korsmeyer RW, Gurny R, Doelker E, et al. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm.1983;15:25--35
   Google Scholar
• Budhian A, Siegel SJ, Winey KI. Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content. Int J Pharm 2007;336:367–375
   PubMed Web of Science ®Google Scholar
• Musumeci T, Ventura C, Giannone A, et al. PLA/PLGA nanoparticles for sustained release of docetaxel. Int J Pharm 2006;325:172–179
   PubMed Web of Science ®Google Scholar
• Bakshi M, Singh B, Singh A, Singh S. The ICH guidance in practice: stress degradation studies on ornidazole and development of a validated stability-indicating assay. J Pharm Biomed Anal 2001;26:891–897
   PubMed Web of Science ®Google Scholar
• Allemann E, Gurny R, Doelker E. Drug loaded nanoparticles preparation methods and drug targeting issues. Eur J Pharm Biopharm 1993;39:173–191
   Web of Science ®Google Scholar
• Dinarvand R, Sepehri N, Manoochehri S, et al. Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents. Int J Nanomedicine 2011;6:877–895
   PubMed Web of Science ®Google Scholar
• Amass W, Amass A, Tighe B. A review of biodegradable polymers: uses, current developments in the synthesis and characterization of biodegradable polyesters, blends of biodegradable polymers and recent advances in biodegradation studies. Polym Int 1998;47:89–144
   Web of Science ®Google Scholar
• Sendil D, Gürsel I, Wise DL, et al. Antibiotic release from biodegradable PHBV microparticles. J Control Release 1999;59:207–217
   PubMed Web of Science ®Google Scholar
• Francis L, Meng D, Knowles J, et al. Controlled delivery of gentamicin using poly(3-hydroxybutyrate) microspheres. Int J Mol Sci 2011;12:4294–4314
   PubMed Web of Science ®Google Scholar
• Box GE, Behnken DW. Some new three level designs for the study of quantitative variables. Technometrics 1960;2:455–475
   Google Scholar
• Ferreira Sl, Bruns RE, Ferreira HS, et al. Box–Behnken design: an alternative for the optimization of analytical methods. Analytica Chim Acta 2007;597:179–186
   PubMed Web of Science ®Google Scholar
• Tewes F, Munnier E, Antoon B, et al. Comparative study of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles prepared by single and double emulsion methods. Eur J Pharm Biopharm 2007;66:488–492
   PubMed Web of Science ®Google Scholar
• Brannon-Peppas L. Recent advances on the use of biode gradable microparticles and nanoparticles in controlled drug delivery. Int J Pharm 1995;116:1–9
   Web of Science ®Google Scholar
• Mao Y, Wang J, Zhao Y, et al. A novel liposomal formulation of FTY720 (Fingolimod) for promising enhanced targeted delivery. Nanomed Nanotech Biol Med 2014;10:393–400
   PubMed Web of Science ®Google Scholar
• Ritger PL, Peppas NA. A simple equation for description of solute release I. Fickian and non-Fickian release from nonswellable devices in the form of slabs, spheres, cylinders or discs. J Control Release 1987;5:23–36
   Google Scholar